Skip to main content
Loading

Antibody affinity maturation strategies: Balancing potency, selectivity, and developability

09 Feb 2027
Lead Identification & Optimization
  • AI/ML-guided design is reshaping the workflow faster than the decision framework; how does this impact your current workflows?

  • Sequential vs. parallel multi-parameter optimization; can it all be done in a single pass?

  • Affinity maturation potentially creates developability and immunogenicity liabilities; how does one balance antibody the TPP and risks?

  • Affinity maturation from display technologies vs. immunization; how different are the approaches from these two discovery modalities?

  • When affinity maturation efforts have failed; what are the next steps?

Industry Expert
Jack Ostrowski, Senior Director Protein Science - Avidity Biosciences